Breast Cancer
Conference Coverage
Think about breast cancer surveillance for transgender patients
CHICAGO - In transgender men, breast cancer can occur years after mastectomy.
Conference Coverage
Over one-third report financial burden from breast cancer treatment
CHICAGO – Out-of-pocket costs pose a financial burden for women weighing breast cancer surgery, but cost transparency is elusive.
Conference Coverage
HDAC inhibition may boost immune therapy efficacy in breast cancer
ORLANDO – Entinostat and nivolumab with or without ipilimumab showed encouraging activity in early results from a phase 1 trial of patients with...
From the Journals
Late toxicities with PARP inhibitor plus RT in inflammatory breast cancer
Using a PARP inhibitor as a radiosensitizer in treatment of women with inflammatory breast cancer was associated with late grade 3 adverse events...
From the Journals
Accelerated breast irradiation advocated by ASTRO guideline
Expanded patient population eligible for whole breast hypofractionated radiation therapy in updated ASTRO guideline.
Conference Coverage
Fulvestrant plus neratinib reversed treatment-acquired HER2 mutations in metastatic ER+ breast cancer
The in vitro success has launched a phase 2 trial recruiting 152 patients.
From the Journals
Gaps exist in receipt of clinically indicated genetic counseling after breast cancer diagnosis
Less than half of patients diagnosed with early breast cancer with an indication for genetic risk evaluation received formal genetic counseling....
Conference Coverage
CECCY: Carvedilol didn’t curb cardiotoxicity in breast cancer patients
ORLANDO – “In short follow up, we can see cardiotoxicity appearing, and we know we have to treat it promptly to prevent cardiac events.”
From the Journals
Age at time of breast cancer diagnosis differs by race/ethnicity
Age-based screening may not provide equal capture rates for whites, nonwhites.
From the Journals
Breast cancer care delayed when patients have high deductibles
Women with an employer-mandated switch from a low- to high-deductible health plan had significant delays in diagnostic imaging, biopsy, diagnosis...
News
FDA authorizes first direct-to-consumer BRCA1/2 test
The test identifies the three most common BRCA1/2 mutations among people of Ashkenazi Jewish descent.